The Ministry of Chemicals and Fertilisers vide its notification dated 27th July 2021 has invited applications to produce Ofloxacin, the fluoroquinolone antibiotic to treat bacterial infections, under the PLI scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs.
The minimum annual production capacity as per scheme guidelines is 100 MT, and one applicant will be selected for the incentive as per the scheme.
The object of the PIL scheme is to attain self-reliance and reduce import dependence in critical KSMs/Dis/APIs. Under the scheme, financial incentives shall be given based on committed investment and sales made by the selected applicant for the eligible products.
The eligible applicants may apply through https://plibulkdrugs.ifciltd.com/ along with supporting documents and application fee.
